IO Biotech (IOBT) Competitors $2.08 +0.17 (+8.90%) Closing price 04:00 PM EasternExtended Trading$2.06 -0.02 (-0.72%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IOBT vs. PRTC, INBX, AUTL, KMDA, AURA, YMAB, VIGL, AQST, OLMA, and RCKTShould you be buying IO Biotech stock or one of its competitors? The main competitors of IO Biotech include PureTech Health (PRTC), Inhibrx Biosciences (INBX), Autolus Therapeutics (AUTL), Kamada (KMDA), Aura Biosciences (AURA), Y-mAbs Therapeutics (YMAB), Vigil Neuroscience (VIGL), Aquestive Therapeutics (AQST), Olema Pharmaceuticals (OLMA), and Rocket Pharmaceuticals (RCKT). These companies are all part of the "pharmaceutical products" industry. IO Biotech vs. Its Competitors PureTech Health Inhibrx Biosciences Autolus Therapeutics Kamada Aura Biosciences Y-mAbs Therapeutics Vigil Neuroscience Aquestive Therapeutics Olema Pharmaceuticals Rocket Pharmaceuticals PureTech Health (NASDAQ:PRTC) and IO Biotech (NASDAQ:IOBT) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends. Does the media favor PRTC or IOBT? In the previous week, PureTech Health had 2 more articles in the media than IO Biotech. MarketBeat recorded 4 mentions for PureTech Health and 2 mentions for IO Biotech. IO Biotech's average media sentiment score of 1.65 beat PureTech Health's score of 0.90 indicating that IO Biotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PureTech Health 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IO Biotech 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more volatility & risk, PRTC or IOBT? PureTech Health has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, IO Biotech has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Do institutionals & insiders believe in PRTC or IOBT? 0.0% of PureTech Health shares are held by institutional investors. Comparatively, 54.8% of IO Biotech shares are held by institutional investors. 5.3% of PureTech Health shares are held by company insiders. Comparatively, 4.8% of IO Biotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is PRTC or IOBT more profitable? PureTech Health's return on equity of 0.00% beat IO Biotech's return on equity.Company Net Margins Return on Equity Return on Assets PureTech HealthN/A N/A N/A IO Biotech N/A -281.82%-169.29% Which has higher earnings and valuation, PRTC or IOBT? PureTech Health has higher revenue and earnings than IO Biotech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPureTech Health$4.83M78.93$27.78MN/AN/AIO BiotechN/AN/A-$95.49M-$1.58-1.32 Do analysts rate PRTC or IOBT? IO Biotech has a consensus price target of $8.00, suggesting a potential upside of 284.62%. Given IO Biotech's stronger consensus rating and higher probable upside, analysts clearly believe IO Biotech is more favorable than PureTech Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PureTech Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00IO Biotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 SummaryPureTech Health beats IO Biotech on 7 of the 13 factors compared between the two stocks. Get IO Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for IOBT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IOBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IOBT vs. The Competition Export to ExcelMetricIO BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$3.20B$5.86B$10.15BDividend YieldN/A2.30%5.68%4.59%P/E Ratio-1.3221.1774.5225.93Price / SalesN/A463.28536.78122.58Price / CashN/A46.6837.5660.44Price / Book2.939.6112.166.29Net Income-$95.49M-$53.29M$3.28B$270.77M7 Day Performance6.67%0.29%0.98%3.36%1 Month Performance58.78%8.91%7.20%6.41%1 Year Performance170.87%13.14%63.06%28.26% IO Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IOBTIO Biotech3.2836 of 5 stars$2.08+8.9%$8.00+284.6%+134.4%$0.00N/A-1.3230Positive NewsPRTCPureTech Health0.5587 of 5 stars$17.07-1.6%$45.00+163.6%-18.0%$411.93M$4.83M0.00100Short Interest ↑INBXInhibrx Biosciences1.294 of 5 stars$28.20+1.1%N/A+89.7%$408.49M$200K-2.67166News CoveragePositive NewsAUTLAutolus Therapeutics3.8377 of 5 stars$1.50-4.5%$9.12+508.0%-65.0%$399.21M$10.12M-1.79330Positive NewsShort Interest ↓KMDAKamada4.5423 of 5 stars$6.92-1.4%$13.00+87.9%+33.3%$397.93M$160.95M20.35360Positive NewsShort Interest ↓AURAAura Biosciences2.2512 of 5 stars$6.26-2.6%$22.00+251.4%-26.8%$388.87MN/A-3.1950Positive NewsYMABY-mAbs Therapeutics2.0717 of 5 stars$8.55+0.1%$9.62+12.5%-35.3%$388.50M$87.68M-17.10150News CoveragePositive NewsVIGLVigil NeuroscienceN/A$8.05flat$10.80+34.2%N/A$383.91MN/A-3.9340AQSTAquestive Therapeutics2.251 of 5 stars$3.77-1.6%$10.14+169.0%+0.0%$375.96M$57.56M-5.39160OLMAOlema Pharmaceuticals2.8454 of 5 stars$5.46-1.1%$24.00+339.6%-35.2%$374.74MN/A-2.7670News CoveragePositive NewsAnalyst UpgradeRCKTRocket Pharmaceuticals4.7919 of 5 stars$3.28-2.1%$16.73+410.2%-82.8%$353.92MN/A-1.31240Short Interest ↑ Related Companies and Tools Related Companies PureTech Health Competitors Inhibrx Biosciences Competitors Autolus Therapeutics Competitors Kamada Competitors Aura Biosciences Competitors Y-mAbs Therapeutics Competitors Vigil Neuroscience Competitors Aquestive Therapeutics Competitors Olema Pharmaceuticals Competitors Rocket Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IOBT) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IO Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IO Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
